Global Dialysis- Market

Dialysis- Comprehensive Study by Type (Hemodialysis, Peritoneal Dialysis), Product & Service (Equipment, Consumables, Services), End User (In-center dialysis, Home dialysis) Players and Region - Global Market Outlook to 2032

Dialysis- Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Dialysis- Market Scope
Dialysis is a life-sustaining medical procedure that replicates many of the essential functions of healthy kidneys by removing waste products, excess fluids, and toxins from the bloodstream when natural kidney function is impaired or lost. This treatment becomes critical for patients with end-stage renal disease or severe chronic kidney failure, allowing them to maintain a balance of electrolytes and fluids that is necessary for survival. There are two primary types of dialysis—hemodialysis and peritoneal dialysis—each offering different approaches and advantages based on patient needs and lifestyle. Hemodialysis involves circulating the patient’s blood through an external machine equipped with a dialyzer, a specialized filter that cleanses the blood by drawing out impurities before returning it to the body. Typically, this process requires several sessions per week, each lasting several hours, thereby demanding a strict schedule that can significantly impact a patient’s daily routine and quality of life. On the other hand, peritoneal dialysis utilizes the patient’s own peritoneum, a natural, semi-permeable membrane lining the abdominal cavity, as the filtering mechanism. In this procedure, a sterile dialysis solution is infused into the abdomen through a catheter; the solution remains for a predetermined dwell time during which waste products and excess fluids diffuse from the blood into the fluid, and then the used solution is drained away. This method can often be performed at home, offering patients greater flexibility and independence compared to the more regimented schedule of hemodialysis. Despite the differences in technique, both forms of dialysis share the common goal of preventing the dangerous build-up of toxins and maintaining the chemical and fluid equilibrium that is vital for the body’s overall health. Advances in medical technology have continually improved the safety, efficiency, and patient comfort associated with dialysis treatments. Innovations such as portable dialysis machines and improved dialyzer membranes have not only enhanced the treatment’s effectiveness but have also contributed to better quality of life by allowing patients more autonomy and reducing the frequency of hospital visits. Nevertheless, dialysis is not without its challenges; patients often face strict dietary restrictions, limitations on fluid intake, and the psychological burden of managing a chronic condition that requires ongoing, invasive treatment.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)
Key Companies ProfiledFresenius Medical Care [Germany], DaVita Inc. [United States], Baxter International Inc. [United States], B. Braun Melsungen AG [Germany], Nipro Corporation [Japan], Gambro [Sweden], NxStage Medical Inc. [United States], Nikkiso Co., Ltd. [Japan], Asahi Kasei Corporation [Japan] and Diaverum [Sweden]
CAGR%


The dialysis market is very competitive, with numerous healthcare providers, equipment manufacturers, and service operators. The market is technologically driven, with companies trying to innovate in developing dialysis machines, home dialysis solutions, and integrated care models. High demand for personalized treatment and cost-effective therapies resulted in massive investments in research and development (R&D). Expanding infrastructures of healthcare, government support, and effective reimbursement policies are also accelerating market competition. Providers' differentiation is also done through service quality, patient outcome, and strategic partnerships for expanding market share and to meet the increasing flow of patients. Research Analyst at AMA estimates that Global Players will contribute to the maximum growth of Global Dialysis- market throughout the predicted period.

Fresenius Medical Care [Germany], DaVita Inc. [United States], Baxter International Inc. [United States], B. Braun Melsungen AG [Germany], Nipro Corporation [Japan], Gambro [Sweden], NxStage Medical Inc. [United States], Nikkiso Co., Ltd. [Japan], Asahi Kasei Corporation [Japan] and Diaverum [Sweden] are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Toray Medical Co., Ltd. [Japan], Nephros, Inc. [United States], American Renal Associates Holdings Inc. [United States], US Renal Care [United States] and Rockwell Medical, Inc. [[United States].

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Dialysis- market by Type and Region with country level break-up.

On the basis of geography, the market of Dialysis- has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2024.

Market Leaders and their expansionary development strategies
In December 2024, Rockwell Medical signed a multi-year agreement with a global leader in dialysis products, projected to generate over USD 10 Million in net sales for 2025. The partnership includes incremental price increases annually and spans up to five years. Rockwell will supply its hemodialysis products to the customer as part of this collaboration. This deal strengthens Rockwell's position in the global dialysis market.
In December 2024, DCDC Health Services Pvt Ltd secured an investment of approximately USD 9.85 Million from British International Investment (BII) to expand its dialysis clinic network. The funding will support the rollout of over 900 dialysis machines across 100+ centers, targeting over 15,000 low-income patients with End-Stage Renal Disease (ESRD). The expansion is projected to create approximately 1,000 direct jobs within the next 3 years. This initiative aims to deliver critical, life-saving dialysis treatments to underserved communities.


Influencing Trend:
Increasing lifestyle changes lead to kidney complications

Market Growth Drivers:
Rising demand for Improved Peritoneal Dialysis Techniques

Challenges:
Infrastructure and Access Limitations

Restraints:
High Treatment Costs

Opportunities:
Expansion of private dialysis clinics and centers

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Strategic Business Planners, Government Regulatory, Research Organizations, End-Use Industries and Others

Report Objectives / Segmentation Covered

By Type
By Type
  • Hemodialysis
  • Peritoneal Dialysis

By Product & Service
  • Equipment
  • Consumables
  • Services

By End User
  • In-center dialysis
  • Home dialysis

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising demand for Improved Peritoneal Dialysis Techniques
    • 3.3. Market Challenges
      • 3.3.1. Infrastructure and Access Limitations
    • 3.4. Market Trends
      • 3.4.1. Increasing lifestyle changes lead to kidney complications
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dialysis-, by Type, Product & Service , End User and Region (value) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Dialysis- (Value)
      • 5.2.1. Global Dialysis- by: Type (Value)
        • 5.2.1.1. Hemodialysis
        • 5.2.1.2. Peritoneal Dialysis
      • 5.2.2. Global Dialysis- by: Type (Value)
        • 5.2.2.1. Hemodialysis
        • 5.2.2.2. Peritoneal Dialysis
      • 5.2.3. Global Dialysis- by: End User (Value)
        • 5.2.3.1. In-center dialysis
        • 5.2.3.2. Home dialysis
      • 5.2.4. Global Dialysis- Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Dialysis-: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Fresenius Medical Care [Germany]
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. DaVita Inc. [United States]
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Baxter International Inc. [United States]
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun Melsungen AG [Germany]
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nipro Corporation [Japan]
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Gambro [Sweden]
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. NxStage Medical Inc. [United States]
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Nikkiso Co., Ltd. [Japan]
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Asahi Kasei Corporation [Japan]
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Diaverum [Sweden]
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Dialysis- Sale, by Type, Product & Service , End User and Region (value) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Dialysis- (Value)
      • 7.2.1. Global Dialysis- by: Type (Value)
        • 7.2.1.1. Hemodialysis
        • 7.2.1.2. Peritoneal Dialysis
      • 7.2.2. Global Dialysis- by: Type (Value)
        • 7.2.2.1. Hemodialysis
        • 7.2.2.2. Peritoneal Dialysis
      • 7.2.3. Global Dialysis- by: End User (Value)
        • 7.2.3.1. In-center dialysis
        • 7.2.3.2. Home dialysis
      • 7.2.4. Global Dialysis- Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dialysis-: by Type(USD Million)
  • Table 2. Dialysis- Hemodialysis , by Region USD Million (2019-2024)
  • Table 3. Dialysis- Peritoneal Dialysis , by Region USD Million (2019-2024)
  • Table 4. Dialysis-: by Type(USD Million)
  • Table 5. Dialysis- Hemodialysis , by Region USD Million (2019-2024)
  • Table 6. Dialysis- Peritoneal Dialysis , by Region USD Million (2019-2024)
  • Table 7. Dialysis-: by End User(USD Million)
  • Table 8. Dialysis- In-center dialysis , by Region USD Million (2019-2024)
  • Table 9. Dialysis- Home dialysis , by Region USD Million (2019-2024)
  • Table 10. South America Dialysis-, by Country USD Million (2019-2024)
  • Table 11. South America Dialysis-, by Type USD Million (2019-2024)
  • Table 12. South America Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 13. South America Dialysis-, by End User USD Million (2019-2024)
  • Table 14. Brazil Dialysis-, by Type USD Million (2019-2024)
  • Table 15. Brazil Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 16. Brazil Dialysis-, by End User USD Million (2019-2024)
  • Table 17. Argentina Dialysis-, by Type USD Million (2019-2024)
  • Table 18. Argentina Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 19. Argentina Dialysis-, by End User USD Million (2019-2024)
  • Table 20. Rest of South America Dialysis-, by Type USD Million (2019-2024)
  • Table 21. Rest of South America Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 22. Rest of South America Dialysis-, by End User USD Million (2019-2024)
  • Table 23. Asia Pacific Dialysis-, by Country USD Million (2019-2024)
  • Table 24. Asia Pacific Dialysis-, by Type USD Million (2019-2024)
  • Table 25. Asia Pacific Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 26. Asia Pacific Dialysis-, by End User USD Million (2019-2024)
  • Table 27. China Dialysis-, by Type USD Million (2019-2024)
  • Table 28. China Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 29. China Dialysis-, by End User USD Million (2019-2024)
  • Table 30. Japan Dialysis-, by Type USD Million (2019-2024)
  • Table 31. Japan Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 32. Japan Dialysis-, by End User USD Million (2019-2024)
  • Table 33. India Dialysis-, by Type USD Million (2019-2024)
  • Table 34. India Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 35. India Dialysis-, by End User USD Million (2019-2024)
  • Table 36. South Korea Dialysis-, by Type USD Million (2019-2024)
  • Table 37. South Korea Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 38. South Korea Dialysis-, by End User USD Million (2019-2024)
  • Table 39. Taiwan Dialysis-, by Type USD Million (2019-2024)
  • Table 40. Taiwan Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 41. Taiwan Dialysis-, by End User USD Million (2019-2024)
  • Table 42. Australia Dialysis-, by Type USD Million (2019-2024)
  • Table 43. Australia Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 44. Australia Dialysis-, by End User USD Million (2019-2024)
  • Table 45. Rest of Asia-Pacific Dialysis-, by Type USD Million (2019-2024)
  • Table 46. Rest of Asia-Pacific Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 47. Rest of Asia-Pacific Dialysis-, by End User USD Million (2019-2024)
  • Table 48. Europe Dialysis-, by Country USD Million (2019-2024)
  • Table 49. Europe Dialysis-, by Type USD Million (2019-2024)
  • Table 50. Europe Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 51. Europe Dialysis-, by End User USD Million (2019-2024)
  • Table 52. Germany Dialysis-, by Type USD Million (2019-2024)
  • Table 53. Germany Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 54. Germany Dialysis-, by End User USD Million (2019-2024)
  • Table 55. France Dialysis-, by Type USD Million (2019-2024)
  • Table 56. France Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 57. France Dialysis-, by End User USD Million (2019-2024)
  • Table 58. Italy Dialysis-, by Type USD Million (2019-2024)
  • Table 59. Italy Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 60. Italy Dialysis-, by End User USD Million (2019-2024)
  • Table 61. United Kingdom Dialysis-, by Type USD Million (2019-2024)
  • Table 62. United Kingdom Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 63. United Kingdom Dialysis-, by End User USD Million (2019-2024)
  • Table 64. Netherlands Dialysis-, by Type USD Million (2019-2024)
  • Table 65. Netherlands Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 66. Netherlands Dialysis-, by End User USD Million (2019-2024)
  • Table 67. Rest of Europe Dialysis-, by Type USD Million (2019-2024)
  • Table 68. Rest of Europe Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 69. Rest of Europe Dialysis-, by End User USD Million (2019-2024)
  • Table 70. MEA Dialysis-, by Country USD Million (2019-2024)
  • Table 71. MEA Dialysis-, by Type USD Million (2019-2024)
  • Table 72. MEA Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 73. MEA Dialysis-, by End User USD Million (2019-2024)
  • Table 74. Middle East Dialysis-, by Type USD Million (2019-2024)
  • Table 75. Middle East Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 76. Middle East Dialysis-, by End User USD Million (2019-2024)
  • Table 77. Africa Dialysis-, by Type USD Million (2019-2024)
  • Table 78. Africa Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 79. Africa Dialysis-, by End User USD Million (2019-2024)
  • Table 80. North America Dialysis-, by Country USD Million (2019-2024)
  • Table 81. North America Dialysis-, by Type USD Million (2019-2024)
  • Table 82. North America Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 83. North America Dialysis-, by End User USD Million (2019-2024)
  • Table 84. United States Dialysis-, by Type USD Million (2019-2024)
  • Table 85. United States Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 86. United States Dialysis-, by End User USD Million (2019-2024)
  • Table 87. Canada Dialysis-, by Type USD Million (2019-2024)
  • Table 88. Canada Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 89. Canada Dialysis-, by End User USD Million (2019-2024)
  • Table 90. Mexico Dialysis-, by Type USD Million (2019-2024)
  • Table 91. Mexico Dialysis-, by Product & Service USD Million (2019-2024)
  • Table 92. Mexico Dialysis-, by End User USD Million (2019-2024)
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Dialysis-: by Type(USD Million)
  • Table 104. Dialysis- Hemodialysis , by Region USD Million (2027-2032)
  • Table 105. Dialysis- Peritoneal Dialysis , by Region USD Million (2027-2032)
  • Table 106. Dialysis-: by Type(USD Million)
  • Table 107. Dialysis- Hemodialysis , by Region USD Million (2027-2032)
  • Table 108. Dialysis- Peritoneal Dialysis , by Region USD Million (2027-2032)
  • Table 109. Dialysis-: by End User(USD Million)
  • Table 110. Dialysis- In-center dialysis , by Region USD Million (2027-2032)
  • Table 111. Dialysis- Home dialysis , by Region USD Million (2027-2032)
  • Table 112. South America Dialysis-, by Country USD Million (2027-2032)
  • Table 113. South America Dialysis-, by Type USD Million (2027-2032)
  • Table 114. South America Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 115. South America Dialysis-, by End User USD Million (2027-2032)
  • Table 116. Brazil Dialysis-, by Type USD Million (2027-2032)
  • Table 117. Brazil Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 118. Brazil Dialysis-, by End User USD Million (2027-2032)
  • Table 119. Argentina Dialysis-, by Type USD Million (2027-2032)
  • Table 120. Argentina Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 121. Argentina Dialysis-, by End User USD Million (2027-2032)
  • Table 122. Rest of South America Dialysis-, by Type USD Million (2027-2032)
  • Table 123. Rest of South America Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 124. Rest of South America Dialysis-, by End User USD Million (2027-2032)
  • Table 125. Asia Pacific Dialysis-, by Country USD Million (2027-2032)
  • Table 126. Asia Pacific Dialysis-, by Type USD Million (2027-2032)
  • Table 127. Asia Pacific Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 128. Asia Pacific Dialysis-, by End User USD Million (2027-2032)
  • Table 129. China Dialysis-, by Type USD Million (2027-2032)
  • Table 130. China Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 131. China Dialysis-, by End User USD Million (2027-2032)
  • Table 132. Japan Dialysis-, by Type USD Million (2027-2032)
  • Table 133. Japan Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 134. Japan Dialysis-, by End User USD Million (2027-2032)
  • Table 135. India Dialysis-, by Type USD Million (2027-2032)
  • Table 136. India Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 137. India Dialysis-, by End User USD Million (2027-2032)
  • Table 138. South Korea Dialysis-, by Type USD Million (2027-2032)
  • Table 139. South Korea Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 140. South Korea Dialysis-, by End User USD Million (2027-2032)
  • Table 141. Taiwan Dialysis-, by Type USD Million (2027-2032)
  • Table 142. Taiwan Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 143. Taiwan Dialysis-, by End User USD Million (2027-2032)
  • Table 144. Australia Dialysis-, by Type USD Million (2027-2032)
  • Table 145. Australia Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 146. Australia Dialysis-, by End User USD Million (2027-2032)
  • Table 147. Rest of Asia-Pacific Dialysis-, by Type USD Million (2027-2032)
  • Table 148. Rest of Asia-Pacific Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 149. Rest of Asia-Pacific Dialysis-, by End User USD Million (2027-2032)
  • Table 150. Europe Dialysis-, by Country USD Million (2027-2032)
  • Table 151. Europe Dialysis-, by Type USD Million (2027-2032)
  • Table 152. Europe Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 153. Europe Dialysis-, by End User USD Million (2027-2032)
  • Table 154. Germany Dialysis-, by Type USD Million (2027-2032)
  • Table 155. Germany Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 156. Germany Dialysis-, by End User USD Million (2027-2032)
  • Table 157. France Dialysis-, by Type USD Million (2027-2032)
  • Table 158. France Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 159. France Dialysis-, by End User USD Million (2027-2032)
  • Table 160. Italy Dialysis-, by Type USD Million (2027-2032)
  • Table 161. Italy Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 162. Italy Dialysis-, by End User USD Million (2027-2032)
  • Table 163. United Kingdom Dialysis-, by Type USD Million (2027-2032)
  • Table 164. United Kingdom Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 165. United Kingdom Dialysis-, by End User USD Million (2027-2032)
  • Table 166. Netherlands Dialysis-, by Type USD Million (2027-2032)
  • Table 167. Netherlands Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 168. Netherlands Dialysis-, by End User USD Million (2027-2032)
  • Table 169. Rest of Europe Dialysis-, by Type USD Million (2027-2032)
  • Table 170. Rest of Europe Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 171. Rest of Europe Dialysis-, by End User USD Million (2027-2032)
  • Table 172. MEA Dialysis-, by Country USD Million (2027-2032)
  • Table 173. MEA Dialysis-, by Type USD Million (2027-2032)
  • Table 174. MEA Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 175. MEA Dialysis-, by End User USD Million (2027-2032)
  • Table 176. Middle East Dialysis-, by Type USD Million (2027-2032)
  • Table 177. Middle East Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 178. Middle East Dialysis-, by End User USD Million (2027-2032)
  • Table 179. Africa Dialysis-, by Type USD Million (2027-2032)
  • Table 180. Africa Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 181. Africa Dialysis-, by End User USD Million (2027-2032)
  • Table 182. North America Dialysis-, by Country USD Million (2027-2032)
  • Table 183. North America Dialysis-, by Type USD Million (2027-2032)
  • Table 184. North America Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 185. North America Dialysis-, by End User USD Million (2027-2032)
  • Table 186. United States Dialysis-, by Type USD Million (2027-2032)
  • Table 187. United States Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 188. United States Dialysis-, by End User USD Million (2027-2032)
  • Table 189. Canada Dialysis-, by Type USD Million (2027-2032)
  • Table 190. Canada Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 191. Canada Dialysis-, by End User USD Million (2027-2032)
  • Table 192. Mexico Dialysis-, by Type USD Million (2027-2032)
  • Table 193. Mexico Dialysis-, by Product & Service USD Million (2027-2032)
  • Table 194. Mexico Dialysis-, by End User USD Million (2027-2032)
  • Table 195. Research Programs/Design for This Report
  • Table 196. Key Data Information from Secondary Sources
  • Table 197. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dialysis-: by Type USD Million (2019-2024)
  • Figure 5. Global Dialysis-: by Type USD Million (2019-2024)
  • Figure 6. Global Dialysis-: by End User USD Million (2019-2024)
  • Figure 7. South America Dialysis- Share (%), by Country
  • Figure 8. Asia Pacific Dialysis- Share (%), by Country
  • Figure 9. Europe Dialysis- Share (%), by Country
  • Figure 10. MEA Dialysis- Share (%), by Country
  • Figure 11. North America Dialysis- Share (%), by Country
  • Figure 12. Global Dialysis- share by Players 2024 (%)
  • Figure 13. Global Dialysis- share by Players (Top 3) 2024(%)
  • Figure 14. Global Dialysis- share by Players (Top 5) 2024(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Fresenius Medical Care [Germany] Revenue, Net Income and Gross profit
  • Figure 17. Fresenius Medical Care [Germany] Revenue: by Geography 2024
  • Figure 18. DaVita Inc. [United States] Revenue, Net Income and Gross profit
  • Figure 19. DaVita Inc. [United States] Revenue: by Geography 2024
  • Figure 20. Baxter International Inc. [United States] Revenue, Net Income and Gross profit
  • Figure 21. Baxter International Inc. [United States] Revenue: by Geography 2024
  • Figure 22. B. Braun Melsungen AG [Germany] Revenue, Net Income and Gross profit
  • Figure 23. B. Braun Melsungen AG [Germany] Revenue: by Geography 2024
  • Figure 24. Nipro Corporation [Japan] Revenue, Net Income and Gross profit
  • Figure 25. Nipro Corporation [Japan] Revenue: by Geography 2024
  • Figure 26. Gambro [Sweden] Revenue, Net Income and Gross profit
  • Figure 27. Gambro [Sweden] Revenue: by Geography 2024
  • Figure 28. NxStage Medical Inc. [United States] Revenue, Net Income and Gross profit
  • Figure 29. NxStage Medical Inc. [United States] Revenue: by Geography 2024
  • Figure 30. Nikkiso Co., Ltd. [Japan] Revenue, Net Income and Gross profit
  • Figure 31. Nikkiso Co., Ltd. [Japan] Revenue: by Geography 2024
  • Figure 32. Asahi Kasei Corporation [Japan] Revenue, Net Income and Gross profit
  • Figure 33. Asahi Kasei Corporation [Japan] Revenue: by Geography 2024
  • Figure 34. Diaverum [Sweden] Revenue, Net Income and Gross profit
  • Figure 35. Diaverum [Sweden] Revenue: by Geography 2024
  • Figure 36. Global Dialysis-: by Type USD Million (2027-2032)
  • Figure 37. Global Dialysis-: by Type USD Million (2027-2032)
  • Figure 38. Global Dialysis-: by End User USD Million (2027-2032)
  • Figure 39. South America Dialysis- Share (%), by Country
  • Figure 40. Asia Pacific Dialysis- Share (%), by Country
  • Figure 41. Europe Dialysis- Share (%), by Country
  • Figure 42. MEA Dialysis- Share (%), by Country
  • Figure 43. North America Dialysis- Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Fresenius Medical Care [Germany]
  • DaVita Inc. [United States]
  • Baxter International Inc. [United States]
  • B. Braun Melsungen AG [Germany]
  • Nipro Corporation [Japan]
  • Gambro [Sweden]
  • NxStage Medical Inc. [United States]
  • Nikkiso Co., Ltd. [Japan]
  • Asahi Kasei Corporation [Japan]
  • Diaverum [Sweden]
Additional players considered in the study are as follows:
Toray Medical Co., Ltd. [Japan] , Nephros, Inc. [United States] , American Renal Associates Holdings Inc. [United States] , US Renal Care [United States] , Rockwell Medical, Inc. [[United States]
Select User Access Type

Key Highlights of Report


Feb 2025 205 Pages 53 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Dialysis- Market Quantitative research analysis
Global Dialysis- Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Dialysis- Market are by end use application [].
The Dialysis- Market is gaining popularity and expected to see strong valuation by 2032.
  • Rising demand for Improved Peritoneal Dialysis Techniques

Know More About Global Dialysis- Market Report?

Have a Query? Click Here

Other Related Reports

Robot-Assisted Surgical Systems Comprehensive Study by Type (System, Consumable and Accessories, Software and Services), Application (Gynecological Surgery, Cardiovascular Procedure, Neurosurgery, Or...
$ 3800
Plastic and Paper Straw Comprehensive Study by Type (Kraft Paper Straws, Printed Paper Straws, Plastic Straws), End User (Hotels, Restaurants & Motels, Bars & Lounges, Cafes, Others), Diameter (<0.15...
$ 3800
Managed Wi Fi Solutions Comprehensive Study by Enterprise Size (Small and Medium Businesses (SMBs), Large Enterprises, Hyper-Scale Enterprises), Solution Type (Cloud-Based Managed Wi-Fi, On-Premises ...
$ 3800
Energy Metering SOC Comprehensive Study by Type (Monophase Type, Triphase Type), Application (Commercial, Residential, Industrial) Players and Region - Global Market Outlook to 2032
$ 3800
Beauty and Personal Care- Comprehensive Study by Type (Skincare, Hair Car, Color Cosmetics, Fragrances, Toiletries, Others), Category (Organic Gender, Convectional), Price Range (Premium, Luxury, Bud...
$ 3500